Scarica l'app Stockscreener
37.00
0.76%
0.28
Dopo l'orario di chiusura:
37.00
Precedente Chiudi:
$36.72
Aprire:
$37.07
Volume 24 ore:
750.63K
Relative Volume:
0.85
Capitalizzazione di mercato:
$5.86B
Reddito:
$5.29B
Utile/perdita netta:
$191.46M
Rapporto P/E:
31.40
EPS:
1.1785
Flusso di cassa netto:
$298.82M
1 W Prestazione:
-10.41%
1M Prestazione:
+2.78%
6M Prestazione:
+41.55%
1 anno Prestazione:
+251.04%
Intervallo 1D:
$35.68
$37.40
Intervallo di 1 settimana:
$35.05
$42.53
Portata 52W:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Nome
Pacs Group Inc
Settore
Industria
Telefono
(801) 447-9829
Indirizzo
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
37.00 | 5.83B | 5.29B | 191.46M | 298.82M | 1.1785 |
HCA
Hca Healthcare Inc
|
396.67 | 93.79B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
187.41 | 16.58B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
196.87 | 12.81B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.20 | 11.94B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.99 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-06 | Ripresa | JP Morgan | Overweight |
| 2024-10-09 | Iniziato | UBS | Buy |
| 2024-09-11 | Ripresa | Citigroup | Buy |
| 2024-06-28 | Iniziato | Macquarie | Outperform |
| 2024-05-06 | Iniziato | Citigroup | Buy |
| 2024-05-06 | Iniziato | JP Morgan | Overweight |
| 2024-05-06 | Iniziato | Oppenheimer | Outperform |
| 2024-05-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-05-06 | Iniziato | Stephens | Overweight |
| 2024-05-06 | Iniziato | Truist | Buy |
Mostra tutto
Pacs Group Inc Borsa (PACS) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, I - The National Law Review
PACS Group chief legal officer sells $3.02 million in company stock - Investing.com
[Form 4] PACS Group, Inc. Insider Trading Activity - Stock Titan
PACS Maintains Buy Rating by Truist Securities -- Price Target R - GuruFocus
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast - Investing.com UK
PACS Group Price Target Raised to $52.00/Share From $50.00 by Truist Securities - Moomoo
PACS Group Is Maintained at Buy by Truist Securities - Moomoo
Earnings call transcript: PACS Group Q1 2026 beats EPS forecast By Investing.com - Investing.com Australia
How Pacs Group Inc. (PACS) Affects Rotational Strategy Timing - Stock Traders Daily
Truist Raises Price Target on PACS Group to $52 From $50, Keeps Buy Rating - marketscreener.com
Big U.S. nursing-home group okays $250M buyback after 184% profit jump - Stock Titan
PACS Group's (NYSE:PACS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Truist raises PACS Group stock price target to $52 on guidance - Investing.com Canada
PACS Technical Analysis | Trend, Signals & Chart Patterns | PACS GROUP INC (NYSE:PACS) - ChartMill
PACS Group Q1 earnings call highlights - MSN
PACS Investors Have Opportunity to Lead PACS Group Inc. Securities Fraud Lawsuit - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PACS Group, Inc. (PACS) And Encourages Shareholders to Reach Out - ACCESS Newswire
Is PACS Group (NYSE:PACS) Gaining From NYSE Healthcare Growth? - Kalkine Media
PACS Group (PACS) CFO awarded 48,426 RSUs vesting over three years - Stock Titan
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Sahm
Why PACS Group Stock Is Getting Hammered Today - TipRanks
UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $50 - Moomoo
PACS Group(PACS) Stock Options Chain | Quotes & News - Moomoo
Results: PACS Group, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
UBS Lifts PACS Group Price Target to $50 From $44, Maintains Buy Rating - marketscreener.com
PACS Group Q1 Earnings Call Highlights - sharewise.com
PACS Group (PACS) Is Up 22.1% After Q1 Beat, Guidance Hike and Buyback Launch - Yahoo Finance
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating - Moomoo
PACS Group: Strong Comeback That’s Backed By Improving Fundamentals (NYSE:PACS) - Seeking Alpha
PACS Group | 10-K: FY2025 Annual Report - Moomoo
PACS Group stock rises as RBC Capital maintains Outperform rating By Investing.com - Investing.com India
PACS Group stock rises as RBC Capital maintains Outperform rating - Investing.com UK
RBC Capital Maintains PACS Group(PACS.US) With Buy Rating, Maintains Target Price $52 - Moomoo
Oppenheimer Adjusts Price Target on PACS Group to $48 From $42, Maintains Outperform Rating - marketscreener.com
PACS Group Q1 2026: Revenue Up 11%, EBITDA Surges 75%, But Is the Stock Now Overpriced? - TIKR.com
Assessing PACS Group (PACS) Valuation After Q1 Earnings Beat And New US$250 Million Buyback - Yahoo Finance
Why PACS Group Stock Surged Today - The Motley Fool
PACS Group Earnings Call Shows Profits And Prudence - TipRanks
PACS Group Boosts 2026 Outlook as 1Q Tops Views - Moomoo
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
PACS signals 2026 adjusted EBITDA $605M-$625M while reaffirming revenue $5.65B-$5.75B - MSN
PACS Group Stock Climbs As New CFO Backs Expansion Push - timothysykes.com
PACS Group, Inc. (PACS) Q1 2026 Earnings Call Transcript Summary - Moomoo
PACS Group Stock Jumps as Raised EBITDA Outlook Cuts Through Regulatory Noise - TechStock²
PACS: Q1 2026 delivered strong revenue, earnings, and occupancy, driving higher full-year EBITDA guidance - TradingView
Pacs Group Inc Azioni (PACS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
1.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):